Pharmaceutical & Life Sciences Strategic Consulting
From IND to NDA, launch to post-approval — Pellucid Advantage brings 20+ years of in-house pharmaceutical leadership and independent consulting to your most complex regulatory, clinical, and commercial challenges.
About
Pellucid Advantage was founded more than a decade ago by Eric R. Kinzler, PhD — a seasoned pharmaceutical executive with a doctorate in Cellular and Molecular Biology and more than two decades of experience spanning in-house leadership roles and independent consulting across branded, generic, and investigational products.
Eric has served as Vice President of Medical & Regulatory Affairs, Study Director at GLP/CLIA/CAP-accredited laboratories, Independent Board Member overseeing OIG corporate integrity agreements, and scientific lead at FDA Advisory Committee meetings — including providing expert testimony. Throughout his career, he has helped drive numerous drug approvals and end-to-end product launches, bringing hands-on expertise into several approved applications, class-wide REMS programs, and the creation of quality management systems built from the ground up.
We help growing life sciences companies navigate critical regulatory and quality milestones with confidence. Serving both public and private, branded and generic organizations, we provide executive-level expertise on demand. Whether you’re preparing for your first Agency meeting, advancing a development program, or fulfilling complex post-marketing commitments, we become an extension of your team—bringing the experience, leadership, and strategic insight needed to accelerate progress, mitigate risk, and achieve successful outcomes.
Capabilities
Pre-IND through NDA/ANDA strategy, FDA meeting preparation and facilitation, Advisory Committee support including expert testimony, clinical data analysis and interpretation, and regulatory document development.
End-to-end launch readiness: go-to-market strategy, medical affairs build-out, payer value proposition development, access and reimbursement planning, Scientific Advisory Boards, publication strategy, and promotional material review.
Advertising and promotion strategy, medical-legal-regulatory (MLR) review committee design and facilitation, REMS program management, FDA 483 response, CAPA implementation, and post-marketing commitment oversight.
Design, implementation, and management of QMS aligned with cGMP requirements. Policy and SOP development, compliance training programs, and audit readiness — including FDA and pharmacovigilance inspection support.
Medical information and pharmacovigilance operations, MSL program design, Advisory Board execution, KOL development, scientific communications, and cross-functional support for field teams and strategic partners.
Due diligence support, co-promote structuring, product divestitures, and transfers to new ownership — including supply chain transition, REMS transfers, and regulatory notifications required at change of ownership.
Proprietary analytics platform delivering confidential competitive intelligence and market analytics reports built around your IMS/IQVIA or other sales data, territory structure, and specific business questions.
Expert support for companies developing abuse-deterrent formulations: study protocol design, laboratory oversight, data analysis and interpretation, and preparation of regulatory submissions — including Category 1–4 testing reports aligned with FDA guidance.
Practical AI integration for pharmaceutical and life sciences organizations: workflow automation, intelligent document review, data synthesis, and strategic guidance on deploying AI tools responsibly within regulated environments.
Track Record
Get in Touch
Whether you're preparing for a regulatory milestone, building out your medical affairs function, navigating a compliance challenge, or evaluating a transaction — we'd welcome an introductory conversation.
Engagements are structured to fit your needs: project-based, retainer, or fractional executive support. Confidential. No long-term commitments required to get started.
✉ info@pellucidadvantage.comOver two decades in this industry means a deep bench of trusted colleagues — regulatory counsel, compliance specialists, clinical experts, legal advisors, and commercial strategists across the pharmaceutical and life sciences landscape. If Pellucid Advantage isn't the right fit for your particular challenge, we'll tell you so — and we're always happy to point you toward someone who is.